Abi Jenkins1, Tim Hills2, Mark Santillo3, Mark Gilchrist4. 1. British Society for Antimicrobial Chemotherapy, Griffin House, 53 Regent Place, Birmingham B1 3NJ, UK. 2. Pharmacy Department, Nottingham University Hospitals, Derby Road, Nottingham NG7 2UH, UK. 3. Torbay and South Devon NHSFT, Lawes Bridge, Torquay TQ2 7AA, UK. 4. Pharmacy Department, Imperial College Healthcare Trust, Charing Cross Hospital, London W6 8RF, UK.
Abstract
Background: Outpatient parenteral antimicrobial therapy (OPAT) is an established approach to patient care. A lack of data on antimicrobial stability within administration devices is a barrier to service expansion, and poses an antimicrobial stewardship dilemma. Often broad-spectrum, long half-life agents are used instead of narrow-spectrum agents, which need more frequent administration, but could possibly be used if stability data were available. Objectives: To complete a comprehensive literature review of published antimicrobial stability data, and assess these against a nationally recognized minimum dataset for medicines compounded into administration devices. Methods: Medline, EMBASE, Global Health, International Pharmaceutical Abstracts and Biomedical Research Database were interrogated in April 2014 and updated in November 2015. Results: A total of 420 citations were reviewed with 121 selected for full text review. None of these papers met the inclusion criteria stipulated in the national standards. The most frequent reason for study exclusion was the tolerance limit for the level of the active pharmaceutical ingredient being wider than 95%-105% and absence of 'in-use' testing at 37 °C. Conclusions: This review found no published studies that comply with UK national standards for stability testing. We recommend further research and publication of antimicrobial stability data to support OPAT within the antimicrobial stewardship agenda.
Background: Outpatient parenteral antimicrobial therapy (OPAT) is an established approach to patient care. A lack of data on antimicrobial stability within administration devices is a barrier to service expansion, and poses an antimicrobial stewardship dilemma. Often broad-spectrum, long half-life agents are used instead of narrow-spectrum agents, which need more frequent administration, but could possibly be used if stability data were available. Objectives: To complete a comprehensive literature review of published antimicrobial stability data, and assess these against a nationally recognized minimum dataset for medicines compounded into administration devices. Methods: Medline, EMBASE, Global Health, International Pharmaceutical Abstracts and Biomedical Research Database were interrogated in April 2014 and updated in November 2015. Results: A total of 420 citations were reviewed with 121 selected for full text review. None of these papers met the inclusion criteria stipulated in the national standards. The most frequent reason for study exclusion was the tolerance limit for the level of the active pharmaceutical ingredient being wider than 95%-105% and absence of 'in-use' testing at 37 °C. Conclusions: This review found no published studies that comply with UK national standards for stability testing. We recommend further research and publication of antimicrobial stability data to support OPAT within the antimicrobial stewardship agenda.
Authors: Sara C Keller; Sara E Cosgrove; Michael Kohut; Amanda Krosche; Huai-En Chang; Deborah Williams; Ayse P Gurses Journal: Am J Infect Control Date: 2018-11-22 Impact factor: 2.918
Authors: Edward Raby; Saiyuri Naicker; Fekade Bruck Sime; Laurens Manning; Steven C Wallis; Saurabh Pandey; Jason A Roberts Journal: Eur J Hosp Pharm Date: 2019-12-16
Authors: Conor Jamieson; Laima Ozolina; R Andrew Seaton; Mark Gilchrist; Tim Hills; F Drummond; Alan Shaun Wilkinson Journal: Eur J Hosp Pharm Date: 2020-09-25
Authors: Beatriz Fernández-Rubio; Paula Del Valle-Moreno; Laura Herrera-Hidalgo; Alicia Gutiérrez-Valencia; Rafael Luque-Márquez; Luis E López-Cortés; José María Gutiérrez-Urbón; Sonia Luque-Pardos; Aurora Fernández-Polo; María V Gil-Navarro Journal: Antibiotics (Basel) Date: 2021-12-30